The Rodenstock Company
At the heart of Rodenstock's business strategy is the patented DNEye® Pro technology, with which Rodenstock is the first company to measure the individual shape and size of each eye and produce individualised spectacle lenses, so-called Biometric Intelligent Glasses (B.I.G. VISION®), from thousands of data points.
Founded in 1877 and headquartered in Munich, Germany, the company employs about 5.000 people worldwide and is represented by sales offices and distribution partners in more than 85 countries. Rodenstock is operating with 6 central production plants to secure global supply.
Our Board
Rodenstock is led by an experienced management team.
Our corporate structure
In 2002, Rodenstock set the course towards a corporate structure suitable for the capital market by transforming into a GmbH (limited liability company). In June 2003, Permira Beteiligungsberatung GmbH became the first non-family financial investor. In 2007, the European investment company Bridgepoint took over the shares held by the Permira funds. In 2015, Compass Partners joined Rodenstock as an additional investor.
Apax Funds acquired their shares in March 2021. Apax Funds will support Rodenstock's management in accelerating the company's growth and driving innovation, digitalisation and effective marketing of its products.